Skip to content

Eplerenone

Eplerenone (Inspra) appears in one listed tablet product, Inspra. The Potassium-Sparing Diuretic classification provides context for its listed use for Heart Failure Post-myocardial Infarction. Product details identify the specific presentation and ingredient composition, while the catalogue brings its stated strength and formulation together for comparison.

Inspra

Heart Failure Post-myocardial Infarction

25mg · 50mg

Developed to mitigate heart failure progression to support ventricular recovery and target mineralocorticoid activity.

From$4.26/ tabletView

What treatment context is listed for Eplerenone?

One listed use is Heart Failure Post-myocardial Infarction. Another treatment context is Hypertension. Related medicines appear within Heart & Blood Pressure.

Important safety information for Eplerenone

Information about Eplerenone on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.